Effects of budesonide/formoterol in COPD patients with eosinophilic airway inflammatio
Not Applicable
- Conditions
- CPOD
- Registration Number
- JPRN-UMIN000023312
- Lead Sponsor
- Department of Respiratory Medicine, Shizuoka General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) A Patients with asthma. 2) A patients who have has experienced an acute COPD exacerbation or respiratory tract infection within the past 12 weeks prior to the informed consent 3) A patients receiving oxygen inhalation 4) A patient whom the doctor in charge judged unsuitable as subjected is excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in FEV1 between week 0 and week 8.
- Secondary Outcome Measures
Name Time Method Change in FVC between week 0 and week 8 Change in FEV1/FVC between week 0 and week 8 Change in FOT parameters between week 0 and week 8 Change in CAT between week 0 and week 8 Change in mMRC between week 0 and week 8 Change in FeNO between week 0 and week 8 Change in sputum eosinophils between week 0 and week 8